Wellington Management Group LLP Dyne Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 41,661 shares of DYN stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,661

Previous 226,422 81.6%

Holding current value

$1.18 Million

Previous $7.99 Million 81.28%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $5.9 Million - $8.69 Million	-184,761 Reduced 81.6%	41,661 $1.5 Million
Q2 2024 Aug 13, 2024	SELL	$23.65 - $35.63 $209,680 - $315,895	-8,866 Reduced 3.77%	226,422 $7.99 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $3.07 Million - $6.87 Million	235,288 New	235,288 $6.68 Million
Q4 2023 Feb 12, 2024	BUY	$6.62 - $13.64 $963,037 - $1.98 Million	145,474 New	145,474 $1.93 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $46,190 - $65,418	5,371 Added 4.86%	115,935 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $292,962 - $490,446	34,345 Added 45.06%	110,564 $1.24 Million
Q1 2023 May 12, 2023	SELL	$10.88 - $15.0 $19,812 - $27,315	-1,821 Reduced 2.33%	76,219 $878,000
Q4 2022 Feb 13, 2023	SELL	$9.37 - $13.8 $41,040 - $60,444	-4,380 Reduced 5.31%	78,040 $904,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $91,389 - $192,552	-12,693 Reduced 13.35%	82,420 $1.05 Million
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $10.9 Million - $20.5 Million	-1,667,940 Reduced 94.61%	95,113 $917,000
Q4 2021 Feb 11, 2022	SELL	$11.89 - $16.07 $8.71 Million - $11.8 Million	-732,334 Reduced 29.35%	1,763,053 $21 Million
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $23.6 Million - $32.4 Million	-1,512,045 Reduced 37.73%	2,495,387 $40.5 Million
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $3.45 Million - $4.84 Million	216,655 Added 5.72%	4,007,432 $84.3 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $12.4 Million - $26 Million	886,055 Added 30.5%	3,790,777 $58.9 Million
Q4 2020 Feb 12, 2021	BUY	$16.81 - $23.94 $6.08 Million - $8.67 Million	361,962 Added 14.24%	2,904,722 $60.3 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $50.9 Million - $60.8 Million	2,542,760 New	2,542,760 $49.9 Million

Others Institutions Holding DYN

# of Institutions

210

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.47B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Dyne Therapeutics, Inc. Transaction History